CDC backs full approval of Moderna COVID-19 vaccine
Feb 07, 2022
The Moderna vaccine is the second COVID-19 vaccine to receive full approval from both the FDA and CDC.
Homologous, heterologous COVID-19 boosters are immunogenic
Feb 07, 2022
Antibody neutralizing titers against SARS-CoV-2 D614G pseudovirus increased by a factor of 4 to 73 for all combinations.
Intention to receive COVID-19 vaccine has grown faster among Black adults
Feb 02, 2022
A persistent lower vaccination rate in Black adults might be explained by other factors besides hesitancy.
FDA gives Moderna COVID-19 vaccine full approval
Jan 31, 2022
Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax.
Three mRNA vaccine doses protective against delta, omicron
Jan 28, 2022
However, odds ratios were higher for omicron, suggesting that those booster doses are less protective than they are against delta.
Neutralization titers against omicron up with mRNA-1273 boost
Jan 28, 2022
After a mRNA-1273 (Moderna) boost, neutralization titers against the omicron variant were 20 times higher than than those at one month after second dose.
Third mRNA vaccine dose ups effectiveness against hospitalization
Jan 27, 2022
Vaccine effectiveness against COVID-19 hospitalization is increased with a third dose in those with or without immunocompromising conditions.
Pfizer begins testing COVID-19 vaccine targeted to omicron
Jan 25, 2022
The new U.S. study will assess the updated, omicron-targeted vaccine for use as a booster or for primary vaccinations.
FDA shortens time to booster after Moderna vaccine to five months
Jan 07, 2022
A similar time window for boosters is already in place for people who received the Pfizer–BioNTech vaccine.
Supreme Court hears arguments on Biden’s vaccine mandate for big business
Jan 07, 2022
The court also was hearing arguments on separate vaccine mandate for most heathcare workers.